Literature DB >> 8817977

Effect of pulsatile and nonpulsatile assist on heart and kidney microcirculation with cardiogenic shock.

K Nakata1, M Shiono, Y Orime, M Hata, A Sezai, T Saitoh, Y Sezai.   

Abstract

To estimate microcirculation of the heart and kidney in pulsatile and nonpulsatile-assisted circulation, a comparison study was done using a swine model. Acute myocardial infarction was made by ligation of the left coronary artery branches. After cardiogenic shock, animals were divided into 3 groups as follows: Group C (n = 6), no assist provided; Group NP (n = 6), assisted by a nonpulsatile pump (Bio-Medicus BP-80); Group P (n = 6), supported by a pulsatile pump (Nippon Zeon). left coronary artery flow, endocardial and epicardial regional flows, and renal cortex and medulla tissue blood flows were measured. Left coronary artery flow and endocardial and epicardial tissue blood flows decreased in cardiogenic shock, and they recovered to the control level soon after support in both Group N and Group P. Renal medulla and cortex tissue blood flows decreased in cardiogenic shock, and these flows did not recover in either Group N or P. However, cortex blood flow in Group P did improve, but it did not improve in Group N. These results suggested that pulsatile assist was more effective than nonpulsatile assist for microcirculation after cardiogenic shock to avoid deterioration of major organ functions.

Entities:  

Mesh:

Year:  1996        PMID: 8817977

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  2 in total

1.  Flow field study comparing design iterations of a 50 cc left ventricular assist device.

Authors:  Jason C Nanna; Jennifer A Wivholm; Steven Deutsch; Keefe B Manning
Journal:  ASAIO J       Date:  2011 Sep-Oct       Impact factor: 2.872

2.  In vitro pulsatility analysis of axial-flow and centrifugal-flow left ventricular assist devices.

Authors:  J Ryan Stanfield; Craig H Selzman
Journal:  J Biomech Eng       Date:  2013-03-01       Impact factor: 2.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.